FTO and metabolic dysfunction-associated steatotic liver disease: Haplotype analysis of nine SNPs in FTO was performed to evaluate the effect of haplotypes on NAFLD risk, and no significant relationships were found in all subjects or those with BMI ≥ 25 or < 25 (Tables S3 and S4).